This fact is mainly due to degradation by gastrointestinal tract
enzymes and poor permeability of the intestinal
mucosa [1, 4]. On the other hand, if protein and peptide
drugs administer parenteral, multiple injections are
required in order to achieve desirable therapeutic
effects because of their short half-lives in vivo. The
multiple or frequent injections cause poor compliance.